News & Analysis as of

Multidistrict Litigation

Hissey, Mulderig & Friend, PLLC

Depo-Provera and Meningioma Brain Tumors: What Women Should Know About the Latest Lawsuits

Understanding the Link Between Depo-Provera and Meningioma - In recent years, several major medical studies have identified a potential association between the Depo-Provera birth control shot and the development of meningioma...more

Beveridge & Diamond PC

First-Ever Procedural Rule Issued for MDLs

Beveridge & Diamond PC on

On December 1, 2025, Federal Rule of Civil Procedure 16.1 governing multi-district litigation (MDL) proceedings took effect. This is the first MDL-specific rule and is the culmination of a multiyear-long rulemaking process...more

Herbert Smith Freehills Kramer

New Mass Tort Procedural Rules Have Taken Effect

On December 1, 2025, new Federal Rule of Civil Procedure 16.1 took effect, addressing a gap in the Federal Rules concerning how multidistrict litigation (MDL) should commence following consolidation. MDL is a procedural...more

Morris James LLP

Who Is Eligible to File a Dupixent Lymphoma Lawsuit? Understanding Criteria, Timing, and Next Steps

Morris James LLP on

A diagnosis of T-cell lymphoma after using Dupixent raises serious questions for patients and families. Many want clear answers about whether they may have a legal claim and what criteria determine eligibility. This guide...more

Loeb & Loeb LLP

In re OpenAI, Inc., Copyright Infringement Litigation

Loeb & Loeb LLP on

Finding that OpenAI waived attorney-client privilege in multidistrict litigation over copyright infringement claims, district court grants plaintiffs’ motion to compel OpenAI to produce communications with in-house counsel...more

Jones Day

New Federal Rule Will Help Discourage Meritless Claims in Multidistrict Litigation

Jones Day on

On December 1, 2025, Federal Rule of Civil Procedure 16.1 took effect, providing judges a roadmap for initial case management of multidistrict litigation ("MDLs") and paving the way for early challenges to meritless claims....more

McGinnis Lochridge

2025 Texas Legislative and Procedural Updates

McGinnis Lochridge on

The 2025 Texas legislative session introduced significant reforms impacting business litigation, corporate governance, and court procedures statewide. From expanding the Texas Business Court’s jurisdiction to updating the...more

Arnall Golden Gregory LLP

Settled for Certain? The Latest Proposed Settlement in the Visa and Mastercard MDL Litigation and Its Likely Effect on Surcharging

The multidistrict interchange class action litigation (“Interchange MDL”) against Visa and Mastercard has been going on for over 20 years before the United States District Court for the Eastern District of New York. A unique...more

Venable LLP

Amgen Files Three New Prolia® / Xgeva® BPCIA Litigations Against Proposed Biosimilars AVT03, MB09, and ENZ215

Venable LLP on

On November 6, 2025, Amgen filed its eighth and ninth BPCIA lawsuits against proposed biosimilars of Prolia® / Xgeva® (denosumab), Case No. 1:25-cv-17277 (D.N.J.) against Alvotech and Dr. Reddy’s AVT03 and Case No....more

DLA Piper

Inside Competition: November 2025

DLA Piper on

Inside Competition is designed to help companies identify key legal developments in antitrust and competition law in the United States....more

DLA Piper

New York federal court applies broad preclusive effect and adopts DOJ’s Google ad tech ruling

DLA Piper on

The United States District Court for the Southern District of New York recently ruled, in favor of publishers and advertisers, that Google monopolized worldwide markets for publisher ad servers and ad exchanges and unlawfully...more

A&O Shearman

Minnesota Court Grants in Part and Denies in Part Motion to Dismiss Granulated Sugar Antitrust MDL

A&O Shearman on

On October 15, 2025, Judge Jerry W. Blackwell of the United States District Court for the District of Minnesota granted in part and denied in part defendants’ motions to dismiss a multidistrict litigation alleging a...more

Lighthouse

Untangling Complexity: How to Manage Multijurisdictional Matters in Modern Discovery

Lighthouse on

Summary: Multidistrict litigation demands precision, speed, and coordination across a maze of data and discovery obligations. Here’s how proactive planning and strategic use of AI can help legal teams bring order, and...more

Morrison & Foerster LLP

Litigation Readiness: Seven Things to Keep in Mind (UPDATED)

Data breach class actions inevitably follow from nearly every major security incident. Here are seven things in-house counsel can do to prepare for litigation. 1. Create a Strong Foundation - Depending on the nature and scope...more

Searcy Denney Scarola Barnhart & Shipley

Do You Have a Defective Drug Claim or a Medical Malpractice Claim?

If you have experienced serious or life-altering complications from a drug that your doctor prescribed, you may be entitled to financial compensation for your financial and non-financial losses. ...more

Constangy, Brooks, Smith & Prophete, LLP

Moving ahead: Details of the court-approved Clearview settlement

A federal judge in the Northern District of Illinois approved a settlement in the multidistrict litigation against Clearview AI. The litigation started shortly after a New York Times article in early 2020 highlighted the...more

Pillsbury Winthrop Shaw Pittman LLP

Should Claims of a Link Between Tylenol/Acetaminophen Use and Autism Prompt Regulatory and Litigation Risks, Insurance Coverage...

As debate intensifies over acetaminophen and autism claims, manufacturers, distributors and health care providers should review coverage options to manage potential liabilities....more

Fish & Richardson

Lessons for Biopharma From the Battle of Entresto®

Fish & Richardson on

After more than six years of high-stakes litigation in multiple courts and regulatory fights at the Food and Drug Administration (FDA), generic versions of Novartis Pharmaceuticals Corp. (“Novartis”)’s Entresto® have entered...more

Oberheiden P.C.

Lyft Sexual Assault Lawsuit: Litigation Update and Settlement Information

Oberheiden P.C. on

The rideshare company Lyft is facing multiple lawsuits from passengers who allege that they were sexually assaulted by the company’s drivers. As Lyft sexual assault cases continue to make headlines, we expect that more...more

American Conference Institute (ACI)

[Event] 30th Annual Conference on Drug & Medical Device Litigation - December 3rd - 4th, New York, NY

ACI's 30th Annual Conference on Drug & Medical Device Litigation is the most trusted and anticipated gathering for in-house counsel and leading legal minds across the life sciences industry. With 400+ attendees expected,...more

Venable LLP

FDA Approves Celltrion’s EYLEA® Biosimilar Eydenzelt®

Venable LLP on

On October 9, 2025, Celltrion announced the FDA approved Eydenzelt® (aflibercept-boav), a biosimilar of Regeneron’s EYLEA® (aflibercept). ...more

Mayer Brown

Department of Health and Human Services Links Prenatal Tylenol Use to Autism: Expanding Litigation Risks for Manufacturers,...

Mayer Brown on

On September 22, 2025, the Department of Health and Human Services (HHS) released a report highlighting alleged consistent associations between in utero acetaminophen (Tylenol) exposure and later diagnoses of autism spectrum...more

Venable LLP

Regeneron Settles Litigations with Sandoz and Formycon over EYLEA® Biosimilars Enzeevu™ and Ahzantive®

Venable LLP on

On September 9, 2025, Sandoz announced it reached a settlement agreement with Regeneron, dismissing Case No. 1:24-cv-00085 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.) and allowing the commercialization...more

Alston & Bird

Class Action & MDL Roundup | 2025 Q2 – Exceeding Every Standard

Alston & Bird on

Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the first quarter of 2025. In this edition, the Supreme Court lowers its standards (in ERISA suits), one circuit changes its...more

Goodwin

Aflibercept BPCIA Multi-District Litigation Updates

Goodwin on

The aflibercept multi-district litigation consists of multiple actions consolidated in the Northern District of West Virginia, with Regeneron Pharmaceuticals, Inc. (“Regeneron”) filing suit under the Biologics Price...more

614 Results
 / 
View per page
Page: of 25

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide